SCHEMBL7112432

SCHEMBL7112432

CC(C)(C)C(C=O)NC(=O)c1cc(NC(=O)C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX1 P51575 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 2/20 0.39
NPSR1 Q6W5P4 1/20 0.38
HDAC3 O15379 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
NNMT P40261 1/20 0.37
GPR35 Q9HC97 1/20 0.37
JUN P05412 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
IKBKB O14920 1/20 0.36
BCHE P06276 1/20 0.36
ALDH1A1 P00352 1/20 0.36
EPHX2 P34913 1/20 0.36
NR1H4 Q96RI1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7107168 0.83 TRPA1 (0.45) NPSR1BCHE
SCHEMBL7155398 0.82 TRPA1 (0.50) NPSR1HDAC3NNMTBCHEALDH1A1
SCHEMBL7107910 0.80 NPSR1 (0.41) NPSR1HDAC3HDAC8HDAC6
SCHEMBL7113950 0.78 TRPA1 (0.48) P2RX1LMNAMAPTNPSR1NNMT
SCHEMBL5119432 0.72 NOTUM (0.59) P2RX1MEN1KMT2ALMNAMAPT
SCHEMBL5572981 0.72 MAPT (0.61) P2RX1MEN1KMT2ALMNAMAPT
SCHEMBL25214853 0.69 CA2 (0.36) MEN1KMT2AALDH1A1
SCHEMBL14015103 0.69 MAPT (0.57) P2RX1MEN1KMT2ALMNAMAPT
SCHEMBL7112858 0.67 CCR2 (0.44) P2RX1ALDH1A1
SCHEMBL23148069 0.67 MAPT (0.62) P2RX1LMNAMAPTGPR35ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1351924-A2 DIAMINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Bristol-Myers Squibb Pharma Company (US) 2003-10-15 EP claimed
WO-2002050019-A2 DIAMINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB PHARMA CO. (US) 2002-06-27 WO claimed
EP-1351924-A2 DIAMINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Bristol-Myers Squibb Pharma Company (US) 2003-10-15 EP disclosed
WO-2002050019-A2 DIAMINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB PHARMA CO. (US) 2002-06-27 WO disclosed